Patients with bipolar disorder often face poor health outcomes, especially when treatment plans are followed inconsistently or discontinued. Crest Digital Therapeutics, founded by Stephen Hamm, seeks to improve outcomes for people with bipolar disorder with its software platform that helps keep patients consistent with their treatments. The software will also help detect early warning signs of severe bipolar episodes to mitigate potential harm.
According to Suzanne Blake, “With a pharmaceutical reimbursement business model, Crest Digital Therapeutics is targeting to build its MVP by next year. Having just completed NC State’s National Science Foundation I-Corps program, Hamm said the customer discovery the team has engaged in gives them even more belief in the product moving forward.”
To read more, click here.
(Source: GrepBeat, August 11th, 2022)